Detalles de la búsqueda
1.
Phase IIb study of pembrolizumab combined with S-1 + oxaliplatin or S-1 + cisplatin as first-line chemotherapy for gastric cancer.
Cancer Sci
; 113(8): 2814-2827, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701865
2.
Synchronous multiple primary tumors in patients with malignant lymphoma: a retrospective study.
BMC Cancer
; 22(1): 640, 2022 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690729
3.
[Tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma: real-world data from single institute experience].
Rinsho Ketsueki
; 63(10): 1363-1372, 2022.
Artículo
en Japonés
| MEDLINE | ID: mdl-36351641
4.
Phase II study of cetuximab plus S-1/cisplatin therapy in Japanese patients with advanced gastric cancer.
Jpn J Clin Oncol
; 51(6): 879-885, 2021 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33561262
5.
Characteristics and outcomes of coronavirus disease 2019 (COVID-19) patients with cancer: a single-center retrospective observational study in Tokyo, Japan.
Int J Clin Oncol
; 26(3): 485-493, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33225396
6.
Clinical impact of controlling nutritional status score on the prognosis of patients with diffuse large B-cell lymphoma.
Hematol Oncol
; 38(3): 309-317, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32223021
7.
[Efficacy of Amrubicin Monotherapy for Patients with Extrapulmonary Neuroendocrine Carcinomas Refractory to Platinum-Based Chemotherapy].
Gan To Kagaku Ryoho
; 47(8): 1205-1208, 2020 Aug.
Artículo
en Japonés
| MEDLINE | ID: mdl-32829355
8.
[Clinical Efficacy of mFOLFOX6 for Advanced Gastric Cancer].
Gan To Kagaku Ryoho
; 47(1): 49-53, 2020 Jan.
Artículo
en Japonés
| MEDLINE | ID: mdl-32381862
9.
A subanalysis of Japanese patients in a randomized, double-blind, placebo-controlled, phase 3 trial of nivolumab for patients with advanced gastric or gastro-esophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2).
Gastric Cancer
; 22(2): 344-354, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30506519
10.
Analysis of the prognostic value of BMI and the difference in its impact according to age and sex in DLBCL patients.
Hematol Oncol
; 36(1): 76-83, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449294
11.
Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma.
Ann Hematol
; 97(6): 999-1007, 2018 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-29427185
12.
Ramucirumab for the treatment of metastatic gastric or gastroesophageal junction adenocarcinoma following disease progression on first-line platinum- or fluoropyrimidine-containing combination therapy in Japanese patients: a phase 2, open-label study.
Gastric Cancer
; 21(6): 1041-1049, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29508095
13.
Regional differences in advanced gastric cancer: exploratory analyses of the AVAGAST placebo arm.
Gastric Cancer
; 21(3): 429-438, 2018 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-29058097
14.
Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.
Hematol Oncol
; 35(4): 440-446, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27238634
15.
Central nervous system relapse in patients with diffuse large B cell lymphoma: analysis of the risk factors and proposal of a new prognostic model.
Ann Hematol
; 95(10): 1661-9, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27370993
16.
Subgroup analyses of the safety and efficacy of ramucirumab in Japanese and Western patients in RAINBOW: a randomized clinical trial in second-line treatment of gastric cancer.
Gastric Cancer
; 19(3): 927-38, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26510663
17.
A Phase I Study of S-1 and Gemcitabine with Concurrent Radiotherapy in Patients with Non-Metastatic Advanced Pancreatic Cancer.
Hepatogastroenterology
; 62(140): 1031-6, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26902051
18.
Relative dose intensity of R-CHOP therapy and patient outcomes in advanced follicular lymphoma.
Hematol Oncol
; 37(3): 303-307, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30933366
19.
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study.
Gastric Cancer
; 16(2): 175-82, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22782463
20.
Efficacy of Pembrolizumab Monotherapy in Japanese Patients with Advanced Gastric or Gastroesophageal Junction Cancer.
J Gastrointest Cancer
; 54(3): 951-961, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37037952